| Code | 66875 | ||||||||||
| MA number | 27/0191/09-S | ||||||||||
| Product Form: | tbl 30x0,7 mg (blis.Al/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 27 - ANTIPARKINSONICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister Al/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 30.03.2009 |
| SPC: |
SPC_Glepark 0,18 mg; Glepark 0,7 mg_01.2021.docx
|
| PIL: |
PIL_Glepark 0,18 mg_Glepark 0,7 mg_05.2023.pdf
|
| Safety feature | Yes |
| Data update: | 07.06.2018 |
